Sufentanil Sublingual Tablet Reduces Postoperative Opioid Use Following Outpatient Plastic Surgery
Abstract BackgroundThe emphasis on better pain control with less narcotic use represents an ongoing challenge for outpatient plastic surgery procedures. Intravenous (IV) bolus opioids during surgery can lead to short-term relief, but often repeat dosing is required...
Main Author: | Hisham Seify |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2022-05-01
|
Series: | Aesthetic Surgery Journal Open Forum |
Online Access: | https://academic.oup.com/asjopenforum/article-lookup/doi/10.1093/asjof/ojac040 |
Similar Items
-
Awake Plastic Surgery Procedures: The Use of a Sufentanil Sublingual Tablet to Improve Patient Experience
by: Hisham Seify
Published: (2022-01-01) -
Commentary on: Awake Plastic Surgery Procedures: The Use of a Sufentanil Sublingual Tablet to Improve Patient Experience
by: Mikaela L Kislevitz, et al.
Published: (2022-02-01) -
Sublingual sufentanil for postoperative pain relief: first clinical experiences
by: Meijer F, et al.
Published: (2018-05-01) -
Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study
by: Marco Scardino, et al.
Published: (2018-03-01) -
Sufentanil Sublingual Tablet System (SSTS) for the management of postoperative pain after major abdominal and gynecological surgery within an ERAS protocol: an observational study
by: Turi S, et al.
Published: (2019-07-01)